Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Yet again, US FDA holds off watchman approval for Boston

This article was originally published in Clinica

Executive Summary

US approval of the Watchman stroke prevention device remains out of reach for its manufacturer, Boston Scientific, after the US FDA asked for another advisory panel meeting – the third since 2009. While Leerink analyst Danielle Antalffy believes premarket approval of the left atrial appendage closure device is not a complete write-off, Boston has said that the decision will delay the launch to, at earliest, the first half of 2015.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts